Cardiovascular Biomarkers: Pathophysiology and Disease Management by David A. MorrowCardiovascular Biomarkers: Pathophysiology and Disease Management by David A. Morrow

Cardiovascular Biomarkers: Pathophysiology and Disease Management

EditorDavid A. Morrow

Paperback | November 9, 2010

Pricing and Purchase Info

$479.95

Earn 2400 plum® points
Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

Internationally recognized opinion makers and experts in clinical and laboratory medicine synthesize the latest developments in the use of cardiac biomarkers by the practicing physician. The authors focus on integrating biomarkers into the contemporary clinical management of patients with cardiovascular disease, emphasizing clinical studies, evidence-based diagnostic algorithms, and critical pathways for triage and therapy, whenever available. They also illuminate the connections between specific biomarkers and the basic pathophysiology of cardiovascular disease, explain the analytical properties of the assays relevant to clinical practice, and highlight emerging novel biomarkers and new direction for biomarker development. Numerous figures, illustrations, and tables make key evidence and practical guidelines easily accessible. The book makes clear as never before to today's busy cardiologists, emergency room physicians, and internists how the various assays perform, which ones they should order to evaluate their patients, and how they might change their therapeutic approach based on the results of a biomarker assay.
Title:Cardiovascular Biomarkers: Pathophysiology and Disease ManagementFormat:PaperbackDimensions:640 pages, 10 × 7.01 × 0 inPublished:November 9, 2010Publisher:Humana PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617376205

ISBN - 13:9781617376207

Look for similar items by category:

Reviews

Table of Contents

Part I. Biomarkers of NecrosisBiomarkers of Myocardial Necrosis: Past, Present, and FutureRobert H. Christenson and Hassan M. E. AzzazyAnalytical Issues for the Clinical Use of Cardiac TroponinAlan H. B. WuDefining Myocardial InfarctionAllan S. Jaffe and Luciano BabuinBiomarkers in the Emergency Department: Rapid Diagnosis and TriageJin H. Han and W. Brian GiblerCardiac Troponin for Risk Assessment and Management of Non-ST-Elevation Acute Coronary SyndromeBertil LindahlBiomarkers of Necrosis for Risk Assessment and Management of ST-Elevation Myocardial InfarctionEvangelos Giannitsis and Hugo A. KatusCardiac Troponin After Revascularization ProceduresWarren J. Cantor and L. Kristin NewbyBiomarkers of Necrosis in Heart Failure: Past, Present, and Future DirectionsEmil Missov, James Rider, and Leslie MillerIs There a Role for Cardiac Troponin and Other Biomarkers in Patients With Pulmonary Embolism?Samuel Z. GoldhaberCardiac Troponin in Conditions Other Than Acute Coronary SyndromesFred S. Apple and David A. MorrowDegradation of Cardiac Troponins: Implications for Clinical PracticeAllan S. Jaffe and Jennifer E. Van EykPart II. Biomarkers of IschemiaDeveloping a Marker of Ischemia: Clinical and Research ChallengesRobert L. JesseEmerging Biomarkers of Myocardial IschemiaJesse E. AdamsPart III. Biomarkers of InflammationInflammation in Cardiovascular Disease: The Biological Basis of Inflammatory BiomarkersPeter LibbyAnalytic Issues for the Clinical Use of C-Reactive ProteinNader RifaiC-Reactive Protein as a Tool for Risk Assessment in Primary PreventionShari S. Bassuk and Paul M RidkerHigh-Sensitivity C-Reactive Protein for Risk Assessment in Acute Coronary SyndromesLuigi M. Biasucci and Antonio AbbateBeyond C-Reactive Protein: Novel Markers of Vascular InflammationChristopher HeeschenBiomarkers of Inflammation: Implications in Patients With Heart FailureBiykem BozkurtBiomarkers of Infection and Risk of Coronary Heart DiseaseJoseph B. MuhlesteinPart IV. Biomarkers of Hemodynamic StressBiology of the Natriuretic PeptidesCharlotte Kragelund and Torbjørn OmlandAnalytic Issues for the Clinical Use of B-Type Natriuretic Peptide and N-Terminal Pro B-Type Natriuretic PeptideJohannes MairClinical Use of Natriuretic Peptides for the Diagnosis and Management of Heart FailureAlan MaiselNatriuretic Peptides in Acute and Chronic Coronary Artery DiseaseShuaib M. Abdullah and James A. de LemosNovel Markers of Hemodynamic StressEllen O. Weinberg and Richard T. LeePart V. Biomarkers of Platelet Function and HemostasisClinical and Research Applications of Markers of ThrombosisManesh R. Patel and Richard C. BeckerMeasures of Platelet Activation and AggregationJean-Philippe Collet and Gilles MontalescotMonocyte-Platelet Aggregates in Patients With Ischemic Heart DiseaseMatthew D. Linden and Mark I. FurmanPart VI. Biomarkers of Dyslipidemia and Lipid ModificationMeasurement of Atherogenic Lipoproteins in Cardiovascular Risk AssessmentRichard L. Dunbar and Daniel J. RaderLipoprotein-Associated Phospholipase A2 and Other Lipid-Related Biomarkers in Cardiovascular DiseaseNatalie Khuseyinova and Wolfgang KoenigPart VII. Contemporary and Future Applications of Biomarkers in Clinical CareA Multimarker Approach to Evaluation of Patients With Acute Coronary SyndromeDavid A. MorrowCardiac Biomarkers by Point-of-Care TestingPaul O. CollinsonProteomics and Cardiovascular Biomarker DiscoveryEmerson Liu and Robert E. GersztenGenetic Markers in Cardiovascular DiseaseMarc S. SabatineIndex

Editorial Reviews

From the Foreword..."...readers of this text will find it an invaluable resource regardless of their familiarity with the subject."From the reviews:"This book provides a clear presentation of the use of biomarkers in the diagnosis and treatment of cardiovascular diseases. . The author seeks to provide clinicians with an authoritative book on the current state-of-the art in cardiovascular biomarkers. . It is aimed at practicing cardiologists and does an excellent job of defining the development and use of the current set of cardiovascular biomarkers as well as providing insight into the future directions of the field." (Cooper Woods, Doody's Review Service, March, 2008)